Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
Synthetic lethality is a successful strategy employed to develop selective chemotherapeutics against cancer cells. Inactivation of RAD52 is synthetically lethal to homologous recombination (HR) deficient cancer cell lines. Replication protein A (RPA) recruits RAD52 to repair sites, and the formation...
Main Authors: | Mona Al-Mugotir, Jeffrey J Lovelace, Joseph George, Mika Bessho, Dhananjaya Pal, Lucas Struble, Carol Kolar, Sandeep Rana, Amarnath Natarajan, Tadayoshi Bessho, Gloria E O Borgstahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0248941 |
Similar Items
-
Single-molecule observations of hRPA, RAD51, and RAD52 on single-stranded DNA
by: Ma, Chu Jian
Published: (2017) -
Yeast Srs2 Helicase Promotes Redistribution of Single-Stranded DNA-Bound RPA and Rad52 in Homologous Recombination Regulation
by: Luisina De Tullio, et al.
Published: (2017-10-01) -
Structural Basis of Homology-Directed DNA Repair Mediated by RAD52
by: Mika Saotome, et al.
Published: (2018-05-01) -
Reappearance from Obscurity: Mammalian Rad52 in Homologous Recombination
by: Kritika Hanamshet, et al.
Published: (2016-09-01) -
Inactivation of XPF Sensitizes Cancer Cells to Gemcitabine
by: Joseph W. George, et al.
Published: (2019-01-01)